| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7deb92162571d54922b90f1fb7906b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e160f8fd7e266a86a35b37afa4f5295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31abb8c0b342ac79e459755da8119516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b41ba239c733ea095adff4ae815c9e13 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-417
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-221
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-417
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-221 |
| filingDate |
2000-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b26348fbb73069850d5b6be1e429c473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_454438c44fbd790a21f57480655b34db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1658b47edb0ac76a2ba5b1a993276a15 |
| publicationDate |
2000-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0062819-A1 |
| titleOfInvention |
Formulations for detecting asthma |
| abstract |
Improved formulations for detecting asthma are disclosed. The formulations comprise methacholine or histamine in a dry particulate form wherein the particles are of a respirable size, preferably 2 νm to 5 νm. The dry formulations can be inhaled directly from an inhaler and can be used to detect airway narrowing which is diagnostic of asthma. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02100378-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0197887-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023187393-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1584334-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1584334-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02100378-A3 |
| priorityDate |
1999-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |